Cargando…
MON-LB031 Higher Insulin Degrading Enzyme Levels in Subjects with Metabolic Syndrome
Background: With the growing prevalence of obesity, there is also a rise in the incidence of metabolic syndrome (MS). It is characterizes by hyperinsulinemia, increased fasting glucose, hypertriglyceridemia, low HDL, increased waist circumference and hypertension.Insulin-degrading enzyme (IDE) is th...
Autores principales: | Sofer, Yael, Nash, Yuval, Forsht, Ofir, Osher, Esther, Nahary, Limor, Shaklai, Sigal, Tordjman, Karen, Serebro, Merav, Touati, Elia-Belle, Yacobi Bach, Michal, Marcus, Yonit, Tal, Brurya, Sack, Jessica, Sheffer, Gabi, Landis, Nathan, Stern, Naftali, Frenkel, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6550783/ http://dx.doi.org/10.1210/js.2019-MON-LB031 |
Ejemplares similares
-
SUN-LB014 Intermittent Complete Fasting for Complicated Severe Obesity in Older Diabetic Subjects: Preliminary Evidence for Massive Fluid and Fat Loss with Improvement in Cardiac and Renal Failure
por: Stern, Naftali, et al.
Publicado: (2019) -
Endocrinology specialty service for inpatients: an unmet growing need
por: Osher, Esther, et al.
Publicado: (2023) -
SAT-LB035 The G Protein-Coupled Estrogen Receptor GPER Plays a Dominant Role in Human Islet Cell Proliferation upon High Glucose
por: Shaklai, Sigal, et al.
Publicado: (2019) -
Increment in Dietary Potassium Predicts Weight Loss in the Treatment of the Metabolic Syndrome
por: Tal, Brurya, et al.
Publicado: (2019) -
The Effect of the PCSK9 Inhibitor Evolocumab on Aldosterone Secretion among High Cardiovascular Risk Patients: A Pilot Study
por: Izkhakov, Elena, et al.
Publicado: (2021)